Published in J Pharm Pharmacol on October 01, 1979
Effects of repeated treatment with fluoxetine and citalopram, 5-HT uptake inhibitors, on 5-HT1A and 5-HT2 receptors in the rat brain. J Psychiatry Neurosci (1994) 0.85
Parallel changes in dopamine D2 receptor binding in limbic forebrain associated with chronic mild stress-induced anhedonia and its reversal by imipramine. Psychopharmacology (Berl) (1994) 1.17
An epigenetic approach to the treatment of advanced MDS; the experience with the DNA demethylating agent 5-aza-2'-deoxycytidine (decitabine) in 177 patients. Ann Hematol (2005) 1.15
Serotoninergic mechanism of clonidine and apomorphine interaction. Pol J Pharmacol Pharm (1975) 1.07
Elevated levels of tyrosine hydroxylase in the locus coeruleus in major depression. Biol Psychiatry (1999) 1.04
Drugs affecting dopamine neurons and yawning behavior. Pharmacol Biochem Behav (1977) 1.01
PKC 412 FLT3 inhibitor therapy in AML: results of a phase II trial. Ann Hematol (2004) 0.96
Pharmacology and distribution of norepinephrine transporters in the human locus coeruleus and raphe nuclei. J Neurosci (1997) 0.94
Antagonistic effect of cyproheptadine on neuroleptic-induced catalepsy. Pharmacol Biochem Behav (1975) 0.94
Desipramine induces yawning behaviour in rats. Neuropharmacology (1986) 0.93
Dihydropyridine calcium channel antagonists reduce immobility in the mouse behavioral despair test; antidepressants facilitate nifedipine action. Eur J Pharmacol (1987) 0.92
alpha2C adrenoceptors inhibit adenylyl cyclase in mouse striatum: potential activation by dopamine. J Pharmacol Exp Ther (1999) 0.87
Noradrenergic influence on the stereotyped behaviour induced by amphetamine, phenethylamine and apomorphine. J Pharm Pharmacol (1976) 0.84
Chronic treatment with antidepressants prevents the inhibitory effect of small doses of apomorphine on dopamine synthesis and motor activity. Life Sci (1979) 0.83
Effects of imipramine on serotonergic and beta-adrenergic receptor binding in a realistic animal model of depression. Psychopharmacology (Berl) (1994) 0.82
Novelty-oriented behavior in the rat after selective damage of locus coeruleus projections by DSP-4, a new noradrenergic neurotoxin. Pharmacol Biochem Behav (1984) 0.82
Quantitative distribution of monoamine oxidase A in brainstem monoamine nuclei is normal in major depression. Brain Res (1999) 0.82
Some central pharmacological effects of the calcium channel antagonist flunarizine. J Neural Transm Gen Sect (1991) 0.81
Antidepressant-like activity of the melatonin receptor antagonist, luzindole (N-0774), in the mouse behavioral despair test. Eur J Pharmacol (1990) 0.81
Antidepressant drugs given repeatedly increase binding to alpha 1-adrenoceptors in the rat cortex. Eur J Pharmacol (1985) 0.81
Deprivation of REM sleep in the rat and the opioid peptides beta-endorphin and dynorphin. Neurosci Lett (1986) 0.81
Dihydropyridine calcium channel antagonists as antidepressant drugs in mice and rats. Neuropharmacology (1989) 0.80
Effect of nifedipine on the shuttlebox escape deficit induced by inescapable shock in the rat. Eur J Pharmacol (1988) 0.80
Hematopoietic stem cell mobilization with intravenous melphalan and G-CSF in patients with chemoresponsive multiple myeloma: report of a phase II trial. Bone Marrow Transplant (2005) 0.79
Noradrenergic pathology in psychiatric disorders: postmortem studies. CNS Spectr (2001) 0.79
Chronic treatment with antidepressant drugs: potentiation of apomorphine-induced aggressive behaviour in rats. Neurosci Lett (1979) 0.79
MK-801 elevates the extracellular concentration of dopamine in the rat prefrontal cortex and increases the density of striatal dopamine D1 receptors. Brain Res (1993) 0.79
Hypotheses concerning the mechanism of action of antidepressant drugs. Rev Physiol Biochem Pharmacol (1984) 0.79
Suppressant effect of REM sleep deprivation on neophobia in normal rats and in rats with selective DSP-4 induced damage of locus coeruleus neurons. Pharmacol Biochem Behav (1985) 0.78
REM sleep deprivation changes behavioral response to catecholaminergic and serotonergic receptor activation in rats. Pharmacol Biochem Behav (1981) 0.78
Effect of chronic administration of antidepressant drugs on the noradrenaline disappearance induced by FLA-63 in the rat brain. Pol J Pharmacol Pharm (1979) 0.78
Clonidine and a beta-agonists induce hyperthermia in rats at high ambient temperature. J Neural Transm (1985) 0.78
Desipramine given repeatedly enhances behavioural effects of dopamine and d-amphetamine injected into the nucleus accumbens. Eur J Pharmacol (1987) 0.78
Increase in beta- and alpha 1-adrenoceptor binding sites in the rat brain and in the alpha 1-adrenoceptor functional sensitivity after the DSP-4-induced noradrenergic denervation. Pharmacol Biochem Behav (1986) 0.78
Adaptive and differential changes on beta- and alpha 2-adrenoreceptors mediated hyperthermia after chronic treatment with antidepressant drugs in the rat kept at high ambient temperature. J Neural Transm (1985) 0.78
Effects of apomorphine, TL-99 and 3-PPP on yawning in rats. Neuropharmacology (1984) 0.78
The effect of repeated administration of antidepressant drugs on the responsiveness of rats to catecholamine agonists. J Neural Transm (1979) 0.78
Functional supersensitivity to adrenergic agonists in the rat after DSP-4, a selective noradrenergic neurotoxin. Psychopharmacology (Berl) (1983) 0.78
The effect of (+)- and (-)-oxaprotiline administered repeatedly on the dopamine system. J Neural Transm Gen Sect (1991) 0.77
The effect of L-DOPA on brain catecholamines and motility in rats. Psychopharmacologia (1971) 0.77
Results of a phase I/II trial adding carmustine (300 mg/m2) to melphalan (200 mg/m2) in multiple myeloma patients undergoing autologous stem cell transplantation. Leukemia (2006) 0.77
Central effects of repeated treatment with CGP 37849, a competitive NMDA receptor antagonist with potential antidepressant activity. Pol J Pharmacol (1994) 0.77
Strain differences in clonidine-induced aggressiveness in mice and its interaction with the dopamine system. Pharmacol Biochem Behav (1993) 0.77
The effect of L-DOPA and L-5-hydroxytryptophan on the pentetrazole seizures in rats after lesions of the median raphe nucleus and substantia nigra. Pol J Pharmacol Pharm (1980) 0.77
Some behavioral effects of repeated administration of calcium channel antagonists. Pharmacol Biochem Behav (1990) 0.77
Distinct target size of dopamine D-1 and D-2 receptors in rat striatum. Life Sci (1984) 0.77
Different pharmacokinetic and pharmacological effects following acute and chronic treatment with imipramine. J Neural Transm (1982) 0.77
MK-801-induced symptoms of sensitization. The lack of correlation with the extracellular concentration of dopamine in the rat prefrontal cortex. Brain Res (1993) 0.76
Rapid-eye-movement sleep deprivation inhibits clonidine-induced sedation in rats. Eur J Pharmacol (1981) 0.76
Central effects of repeated treatment with bupropion. Pol J Pharmacol Pharm (1986) 0.76
On the anticataleptic action of cyproheptadine. Pharmacol Biochem Behav (1976) 0.76
Evidence for increased apomorphine-sensitive dopaminergic effects after acute treatment with morphine. Psychopharmacology (Berl) (1977) 0.76
Effects of REM sleep deprivation on central alpha 1- and beta-adrenoceptors in rat brain. Pharmacol Biochem Behav (1986) 0.76
Rapid-eye-movement sleep deprivation decreases the density of 3H-dihydroalprenolol and 3H-imipramine binding sites in the rat cerebral cortex. Eur J Pharmacol (1980) 0.76
Facilitated shock-induced aggression after chronic treatment with antidepressant drugs in the rat. Pharmacol Biochem Behav (1981) 0.75
Repeated treatment with clenbuterol produces desensitization of rat brain beta- and alpha 2-adrenoceptors without changes of alpha 1-adrenoceptors. Eur J Pharmacol (1986) 0.75
Age-dependent day/night variations of alpha 1- and beta-adrenoceptors in the rat cerebral cortex. Physiol Behav (1986) 0.75
Influence of salbutamol and other beta-agonists on hypothermia induced by clonidine, apomorphine and reserpine in mice. J Neural Transm (1981) 0.75
The effects of acute and repeated treatment with salbutamol, a beta-adrenoceptor agonist, on clonidine-induced hypoactivity in rats. J Neural Transm (1982) 0.75
Central D-fenfluramine action. Pol J Pharmacol Pharm (1975) 0.75
Altered hindlimb extension in the rat after DSP-4: a useful marker of central noradrenergic depletion. Eur J Pharmacol (1983) 0.75
Molecular size of alpha 1- and beta-adrenoceptors in rat brain cortex as determined by a radiation inactivation method. Eur J Pharmacol (1986) 0.75
Dopamine synthesis: tolerance to haloperidol and supersensitivity to apomorphine depend on presynaptic receptors. Adv Biochem Psychopharmacol (1980) 0.75
Quantitation of tyrosine hydroxylase protein in the locus coeruleus from postmortem human brain. J Neurosci Methods (2000) 0.75
The influence of beta-agonists on normal and clonidine-decelerated noradrenaline turnover in the rat brain. Pol J Pharmacol Pharm (1986) 0.75
[The effect of the deprivation of paradoxical sleep on the rotational and stereotyped behavior induced by selective agonists of the dopamine receptors]. Biull Eksp Biol Med (1990) 0.75
The influence of dopamine-beta-hydroxylase inhibitors on avoidance reaction in rat. Pol J Pharmacol Pharm (1976) 0.75
[Air pollution around the synthetic fabric plant in Zydowce near Szcsecin]. Gig Sanit (1968) 0.75
Facilitation of shock-induced fighting in the rat after DSP-4, a selective noradrenergic neurotoxin. Pharmacol Biochem Behav (1983) 0.75
Spectrum of pharmacological actions on brain dopamine. Indications for development of new psychoactive drugs. Discussion of amantadines as examples of new drugs with special actions on dopamine systems. Pol J Pharmacol Pharm (1977) 0.75
Rapid changes in functional responsiveness of the 5-HT system after single-dose and multiple-dose treatment with antidepressants: effects of maprotiline and oxaprotiline and its enantiomers. J Psychopharmacol (1989) 0.75
Effect of beta-adrenoceptor agonists on apomorphine-induced turning in rats. J Neural Transm (1985) 0.75
[Clopheline-induced aggression in mice: role of genotype and the dopaminergic system]. Biull Eksp Biol Med (1989) 0.75
The influence of antiserotonergic agents on the action of dopaminergic drugs. Pol J Pharmacol Pharm (1977) 0.75
Repeated administration of antidepressant drugs affects the levels of mRNA coding for D1 and D2 dopamine receptors in the rat brain. J Neural Transm (Vienna) (1997) 0.75
High-performance liquid chromatographic method for the determination of sudexanox as the free acid in plasma. J Chromatogr (1986) 0.75
The influence of mianserin and danitracen on the disappearance of noradrenaline in the rat brain. Pol J Pharmacol Pharm (1978) 0.75
Chronic treatment with some atypical antidepressants increases the brain level of 3-methoxy-4-hydroxyphenylglycol (MHPG) in rats. Psychopharmacology (Berl) (1981) 0.75
The influence of mianserin and danitracen, 5--hydroxytryptamine receptor blockers, on the 5--hydroxytryptamine disappearance induced by h22/54 in the rat brain. Pol J Pharmacol Pharm (1978) 0.75
Tolerance to haloperidol effect on dopamine (DA) synthesis is independent from postsynaptic DA receptors. Pharmacol Res Commun (1980) 0.75
Oxaprotiline enantiomers given repeatedly and brain alpha-adrenoceptors. J Neural Transm Gen Sect (1990) 0.75
Central beta- and alpha-adrenolytic activities of adimolol. Pol J Pharmacol Pharm (1987) 0.75
Interaction between beta-adrenoceptor agonists and alpha 1-adrenergic system. A behavioral study with the clonidine-induced aggression test. Pol J Pharmacol Pharm (1987) 0.75
Effect of nomifensine on central 5-hydroxytryptamine neurons. J Neural Transm (1977) 0.75
Are beta- and alpha 2-adrenoceptors co-regulated during their stimulation? Behavioral studies. Pol J Pharmacol Pharm (1987) 0.75
Rapid down-regulation of beta-adrenergic receptors evoked by combined forced swimming test and CGP 37849--a competitive antagonist of NMDA receptors. Pol J Pharmacol (1996) 0.75
The effect of alpha, alpha1-dipyridyl on noradrenaline, dopamine and 5-hydroxytryptamine levels and on dopamine-beta-hydroxylase activity in brain. Pol J Pharmacol Pharm (1976) 0.75
The effects of single and repeated doses of maprotiline, oxaprotiline and its enantiomers on foot-shock induced fighting in rats. Pharmacol Biochem Behav (1983) 0.75
The importance of timing for the action of alpha 1- or beta-agonists: possible relationship with the density of [3H]prazosin and [3H]dihydroalprenolol binding sites. Eur J Pharmacol (1985) 0.75
Chronic treatment with antidepressants: protentiation of clonidine-induced aggression in mice via noradrenergic mechanism. J Neural Transm (1981) 0.75